Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services French Ministry approval recognizes Intravacc as a private ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Doctors battling a rare strain of Ebola in central Africa will probably need to wait many months for a vaccine to be ready ...

Dr Rajeev Jayadevan explains why a vaccine created for one Ebola strain may not necessarily protect against another and why ...

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other similar research efforts are also in the very early stages.

Researchers across the world are working on a hantavirus vaccine, though they say development is in the early stages and rollout could be years away.